Gene: SDR42E1
Official Full Name: short chain dehydrogenase/reductase family 42E, member 1provided by HGNC
Gene Summary: Predicted to enable oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Predicted to be involved in steroid biosynthetic process. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22169 | SDR42E1 Knockout cell line (HeLa) | Human | SDR42E1 | 1:3~1:6 | Negative | Online Inquiry |
KO22170 | SDR42E1 Knockout cell line (HCT 116) | Human | SDR42E1 | 1:2~1:4 | Negative | Online Inquiry |
KO22171 | SDR42E1 Knockout cell line (A549) | Human | SDR42E1 | 1:3~1:4 | Negative | Online Inquiry |
SDR42E1 Gene Knockout Cell Lines are expertly engineered cellular models that enable researchers to study the biological functions and disease mechanisms associated with the SDR42E1 gene. The SDR42E1 gene encodes for a protein that plays a critical role in lipid metabolism and cellular signaling pathways. By utilizing CRISPR/Cas9 technology, our cell lines exhibit precise gene disruption, creating a reliable platform for investigating the effects of SDR42E1 deficiency on cellular physiology and pathology.
The key function of these knockout cell lines resides in their ability to allow for the elucidation of SDR42E1's role in various biological processes, including but not limited to metabolic regulation, inflammation, and potential links to chronic diseases such as obesity and cardiovascular disorders. The knockout model provides a powerful tool to explore the molecular mechanisms underpinning these conditions, paving the way for novel therapeutic strategies.
In the realm of scientific research and clinical applications, SDR42E1 knockout cell lines offer unique advantages over traditional models. They provide a targeted approach to studying gene function, reducing background variability and enhancing reproducibility. Unlike transient transfection methods, these stable cell lines maintain the knockout phenotype over multiple passages, ensuring consistent results across experiments.
For researchers and clinicians looking to advance their understanding of SDR42E1 in health and disease, our product stands out due to its precision gene editing, detailed characterization, and ease of integration into existing experimental workflows. The ability to investigate the specific contributions of SDR42E1 in biological systems makes this tool invaluable for basic research as well as potential translational studies.
Our company prides itself on its expertise in delivering high-quality biological products, bolstered by a commitment to supporting the research community with cutting-edge tools that facilitate groundbreaking discoveries. With SDR42E1 Gene Knockout Cell Lines, we empower scientists to drive forward their research with confidence and clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.